| Latest | F'cast | |
|---|---|---|
| Div Yield | 1.2% | 0.0% |
| Div Cover | 4.1 | n/a |
| Op Mrgn | 6.3% | n/a |
| ROCE | 8.4% |
| Latest | F'cast | |
|---|---|---|
| P/E | 20.7 | n/a |
| PEG | 1.3 | n/a |
| Pr/Revenue | 2.7 | n/a |
| Pr/Book | 2.0 |
| Latest | F'cast | |
|---|---|---|
| Revenue | 40.7% | n/a |
| PBT | -53.6% | n/a |
| EPS | 15.9% | n/a |
| DPS | 10.2% | n/a |
| Year Ending | Revenue (£m) | Pre-tax (£m) | EPS | P/E | PEG | EPS Grth. | Div | Yield |
|---|---|---|---|---|---|---|---|---|
| 31-Dec-20 | 86.80 | 10.09 | 4.38p | 55.5 | n/a | -53% | 1.70p | 0.7% |
| 31-Dec-21 | 108.60 | 21.98 | 9.78p | 34.6 | 0.3 | +123% | 1.95p | 0.6% |
| 31-Dec-22 | 124.33 | 25.91 | 10.47p | 24.7 | 3.5 | +7% | 2.15p | 0.8% |
| 31-Dec-23 | 126.21 | 21.16 | 9.19p | 22.6 | n/a | -12% | 2.36p | 1.1% |
| 31-Dec-24 | 177.52 | 9.82 | 10.65p | 18.6 | 1.2 | +16% | 2.60p | 1.3% |
a. Based on UK GAAP presentation of accounts - includes discontinued activities
| Total Voting Rights | 02-Jan-2026 | 07:00 | RNS |
| Total Voting Rights | 02-Jan-2026 | 07:00 | RNS |
| Total Voting Rights | 28-Nov-2025 | 14:31 | RNS |
| Total Voting Rights | 02-Jan-2026 | ShareCast |
| Bridgepoint said to explore £550m bid for Advanc... | 05-Dec-2025 | ShareCast |
| Advanced Medical Solutions reports sharp rise in... | 17-Sep-2025 | ShareCast |
No deals were found in the last 28 days.
| Currency | UK Pounds |
| Share Price | 220.50p |
| Change Today | -0.50p |
| % Change | -0.23 % |
| 52 Week High | 237.00 |
| 52 Week Low | 176.60 |
| Volume | 703,729 |
| Shares Issued | 219.56m |
| Market Cap | £484.12m |
| Beta | 1.25 |
| RiskGrade | 156 |
| Value |
|
|---|
| Price Trend |
|
|---|
| Income |
|
|---|
| Growth |
|
|---|
| Latest | Previous | |
|---|---|---|
| Interim | Final | |
| Ex-Div | 25-Sep-25 | 19-Jun-25 |
| Paid | 24-Oct-25 | 17-Jul-25 |
| Amount | 0.85p | 1.83p |
| Time | Volume / Share Price |
| 09:25 | 100,000 @ 221.97p |
| 17:05 | 100,000 @ 220.50p |
| 16:37 | 1,762 @ 220.50p |
| 16:35 | 65,985 @ 220.50p |
| 16:35 | 78 @ 220.50p |
| CEO | A Christopher (Chris) Meredith |
| CFO | Eddie Johnson |
You are here: research